W., et al., Role of prostacyclin in the
cardiovascular response to thromboxane A2.
Science, 296, 539-541 (2002).
4. Hall, R. A., et al., Pharmacology of L-655,240 (3-[1-
(4-chlorobenzyl)-5
cytochrome P450c
gene expression by cotransfection with adenovirus
E1A DNA. Eur. J. Biochem., 181, 539-544 (1989).
14. Stein, R., and Ziff, E.B., Repression of insulin gene
expression by adenovirus
5. DeGroot, R., et al., Positive regulation of jun/Ap-1
by E1A. Mol. Cell. Biol., 11, 192-201 (1991).
6. Sassone-Corsi, P., and Borrelli, E., Promoter
transactivation of protooncogenes c-fos and
Kontopidis, G ., et al . 2006 . Chem. Biol. 13, 201; Wang, S ., et al . 2004 . J. Med.
Chem. 47, 1662 .
EGFR Inhibitor
[Cyclopropanecarboxylic acid-(3-(6-(3-trifluoromethyl-phenylamino)-pyrimidin-4-
ylamino
MAPK activated (diphosphorylated p38) M8177 M y y y
537 Negative Control NA
538 p53 P5813 M y n/d n/d
539 p53 P6874 M y n/d n/d
540 phospho-p53 (pSer392) P8982 P y y n/d
541 p53DINP1/SIP P4868 P y y y
542
interactions select
and maintain a specifi c cell fate. Molecular Cell. 2011 Aug 19
4;43:528-539.
Eser U, Falleur-Fettig M, Johnson A, Skotheim J. Commitment to a
cellular transition precedes
620583.1,NP_112282.2 M y y y
537 Negative Control NA
538 p53 P5813 7157 TP53 NP_000537.3 M y n/d n/d
539 p53 P6874 7157 TP53 NP_000537.3 M y n/d n/d
540 phospho-p53 (pSer392) P8982 22059, 7157 Trp53,TP53
_620583.1,NP_112282.2 M y y y
537 Negative Control
538 p53 P5813 7157 TP53 NP_000537.3 M y n/d n/d
539 p53 P6874 7157 TP53 NP_000537.3 M y n/d n/d
540 phospho-p53 (pSer392) P8982 22059, 7157 Trp53,TP53